Logo image
Sign in
Integrating bevacizumab into the management of epithelial ovarian cancer: the controversy of front-line versus recurrent disease
Journal article   Peer reviewed

Integrating bevacizumab into the management of epithelial ovarian cancer: the controversy of front-line versus recurrent disease

Bradley J. Monk, E. Pujade-Lauraine and R. A. Burger
Annals of Oncology, Vol.24, pp.53-58
12/2013

Metrics

4 Record Views

Details